QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
Free Trial

Alzamend Neuro (ALZN) Institutional Ownership

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ALZN Stock Alerts
$0.70
+0.01 (+1.29%)
(As of 10:11 AM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Alzamend Neuro (NASDAQ:ALZN)

Current
Institutional Ownership
Percentage
49.61%
Number of
Institutional Buyers
(last 12 months)
0
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$5.41M
Get ALZN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ALZN Institutional Buying and Selling by Quarter

Alzamend Neuro Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.78,545$70K0.0%-96.1%1.103%
2/15/2024Vanguard Group Inc.78,545$70K0.0%-96.1%1.103%
2/2/2024Truist Financial Corp154,327$137K0.0%-93.3%2.168%
2/15/2023Virtu Financial LLC62,660$35K0.0%N/A0.065%
2/13/2023Charles Schwab Investment Management Inc.53,080$30K0.0%N/A0.055%
2/13/2023Renaissance Technologies LLC49,800$28K0.0%N/A0.052%
2/13/2023Geode Capital Management LLC563,660$318K0.0%+7.2%0.585%
2/10/2023HRT Financial LP57,080$32K0.0%N/A0.059%
11/15/2022Vanguard Group Inc.4,095,775$4.87M0.0%+6,642.3%4.290%
11/15/2022BlackRock Inc.596,129$709K0.0%N/A0.624%
8/15/2022Millennium Management LLC49,223$43K0.0%-65.4%0.052%
8/13/2022Renaissance Technologies LLC65,131$56K0.0%N/A0.068%
6/7/2022Bank of America Corp DE28,197$35K0.0%N/A0.031%
5/11/2022 RFG Advisory LLC250,000$308K0.0%N/A0.277%
5/9/2022Qube Research & Technologies Ltd78,465$97K0.0%N/A0.087%
4/22/2022Truist Financial Corp2,314,907$2.85M0.0%N/A2.569%
1/31/2022Commonwealth Equity Services LLC116,666$221K0.0%N/A0.131%
11/16/2021Schonfeld Strategic Advisors LLC31,600$97K0.0%N/A0.036%
11/16/2021Two Sigma Investments LP172,913$533K0.0%N/A0.199%
11/16/2021Warberg Asset Management LLC14,000$43K0.0%N/A0.016%
11/15/2021Sassicaia Capital Advisers LLC93,762$289K0.8%N/A0.108%
9/17/2021Virtu Financial LLC15,402$135K0.0%N/A0.018%
8/16/2021Cubist Systematic Strategies LLC23,672$207K0.0%N/A0.028%
8/13/2021Geode Capital Management LLC44,600$389K0.0%N/A0.052%
8/11/2021Susquehanna International Group LLP57,030$498K0.0%N/A0.067%
(Data available from 1/1/2016 forward)

ALZN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ALZN shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Alzamend Neuro. The most heavily invested institutionals were BlackRock Inc. ($709K), Geode Capital Management LLC ($318K), RFG Advisory LLC ($308K), Truist Financial Corp ($137K), Qube Research & Technologies Ltd ($97K), Vanguard Group Inc. ($70K), and Millennium Management LLC ($43K).Learn more on ALZN's institutional investors.

What percentage of Alzamend Neuro stock is owned by institutional investors?

49.61% of Alzamend Neuro stock is owned by institutional investors. Learn more on ALZN's institutional investor holdings.

Which institutional investors have been buying Alzamend Neuro stock?

Of the 11 institutional investors that purchased Alzamend Neuro stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($4.04M), Truist Financial Corp ($2.31M), BlackRock Inc. ($596.13K), RFG Advisory LLC ($250K), Renaissance Technologies LLC ($114.93K), Qube Research & Technologies Ltd ($78.47K), and Virtu Financial LLC ($62.66K).

How much institutional buying is happening at Alzamend Neuro?

Institutional investors have bought a total of 7,628,387 shares in the last 24 months. This purchase volume represents approximately $135.01M in transactions.

Which Alzamend Neuro major shareholders have been selling company stock?

The following institutional investors have sold Alzamend Neuro stock in the last 24 months: Vanguard Group Inc. ($3.91M), Truist Financial Corp ($2.16M), and Millennium Management LLC ($93.16K).

How much institutional selling is happening at Alzamend Neuro?

Institutional investors have sold a total of 6,167,159 shares in the last 24 months. This volume of shares sold represents approximately $6.61M in transactions.


Related Companies:
This page (NASDAQ:ALZN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press